Todd A. Gillespie - Concepedia

Author

Todd A. Gillespie

Also Known As

T A Gillespie, T GILLESPIE, T Gillespie, T. A. Gillespie, T. Gillespie, T.A. Gillespie, Todd A Gillespie, Todd A. Gillespie, Todd Gillespie

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Purdue University West Lafayette Merrell University of Beauty Arts and Science Indiana University – Purdue University Indianapolis The Ohio State University at Marion

About

Todd A. Gillespie is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.2K
2	Biochemistry	9	9	220
3	Natural Sciences	6	6	170
4	Social Sciences	2	2	265
5	Engineering	1	1	498

Todd A. Gillespie

Publications

Citations

H-Index

Page 1

	Year	Citations
Direct Molecular Analysis of Whole-Body Animal Tissue Sections by Imaging MALDI Mass Spectrometry Sheerin Khatib-Shahidi, Malin Andersson, Jennifer L. Herman, Analytical Chemistry EngineeringPathologyWhole-body Maldi ImsTissue ImagingTheranostics	2006	498
Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine. Barbara J. Ring, John T. Catlow, Thomas J. Lindsay, Journal of Pharmacology and Experimental Therapeutics	1996	214
Disposition and biotransformation of the antipsychotic agent olanzapine in humans. Kelem Kassahun, Edward L. Mattiuz, Eldon H. Nyhart, PubMed Plasma CompartmentPsychotropic MedicationPsychopharmacologyPharmacotherapySocial Sciences	1997	212
The Disposition of Prasugrel, a Novel Thienopyridine, in Humans Nagy A. Farid, Richard L. Smith, Todd A. Gillespie, Drug Metabolism and Disposition	2007	211
METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS R. Clark Lantz, Todd A. Gillespie, T. J. Rash, Drug Metabolism and Disposition	2003	205
Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection John T. Catlow, Richard D. Barton, Matt Clements, Journal of Chromatography B Biomedical Sciences and Applications MedicineElectrochemical DetectionBioanalysisHuman PlasmaAnalytical Chemistry	1995	105
Three-Dimensional Quantitative Structure Activity Relationship Analyses of Substrates for CYP2B6 Sean Ekins, Gianpaolo Bravi, Barbara J. Ring, Journal of Pharmacology and Experimental Therapeutics	1999	104
Human dolasetron pharmacokinetics: I. Disposition following single‐dose intravenous administration to normal male subjects Harold Boxenbaum, Todd A. Gillespie, Kathleen Heck, Biopharmaceutics & Drug Disposition Therapeutic Drug MonitoringIntravenous AdministrationPharmacological Study5-Hydroxytryptamine AntagonistMedicine	1992	53
Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys. Edward L. Mattiuz, Ronald B. Franklin, Todd A. Gillespie, PubMed Molecular PharmacologyPharmacological StudyRhesus MonkeysMedicinePsychotropic Medication	1997	53
Synthesis and biological activity of some known and putative duloxetine metabolites Fengjiun Kuo, Todd A. Gillespie, P Kulanthaivel, Bioorganic & Medicinal Chemistry Letters Biological ActivityBiochemistryPutative Duloxetine MetabolitesMedicineNatural Sciences	2004	43

Page 1